207940:KRX
Samsung Biologics Co Ltd
₩1,390,000.00
arrow_downward
-1.70%(-24,000.00) 1D
Nov 18, 11:29:39 AM GMT+9 · KRW
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 207940...
Open
₩1,396,000
High
₩1,403,000
Low
₩1,373,000
Mkt. cap
67.50T
Avg. vol.
76.45K
Volume
15.60K
P/E ratio
30.29
52-wk high
₩1,973,600
52-wk low
₩1,150,000
EPS
₩45,897
Shares outstanding
46.29M
No. of employees
5K
Open
₩1,396,000
High
₩1,403,000
Low
₩1,373,000
Mkt. cap
67.50T
Avg. vol.
76.45K
Volume
15.60K
P/E ratio
30.29
52-wk high
₩1,973,600
52-wk low
₩1,150,000
EPS
₩45,897
Shares outstanding
46.29M
No. of employees
5K
News stories
From web sources and news partners
www.famtimes.co.kr
·
1 hour ago
Samsung Biologics employees share insights on welfare and company mission
Profile
Samsung Biologics Co., Ltd. is a global contract development and manufacturing organization headquartered in Songdo, Incheon, South Korea. The biotech division of Samsung Group, its core services range from late discovery to large-scale commercial manufacturing. The company focuses on monoclonal antibodies, bispecific antibodies, antibody-drug conjugates, and mRNA vaccines.
The company has partnered with pharmaceutical companies such as Pfizer, GlaxoSmithKline, Eli Lilly, AstraZeneca and Bristol-Myers Squibb. Wikipedia
About Samsung Biologics Co Ltd
CEOJohn Rim
Employees5.33K
Founded2011
Headquarters-
SectorHealth Care
Industry-
Websitesamsungbiologics.com